|
|
||||||||
The uptake of Pb into human red blood cells has been studied using Pb buffers. Passive Pb movements can be studied conveniently when the cells are depleted of adenosine 5'-triphosphate (ATP), to eliminate active transport, and of inorganic phosphate, to prevent precipitation of lead phosphate. Pb can cross the membrane passively in either direction. Influx and efflux show similar properties. Passive Pb transport is strongly stimulated by HCO3-, and is reduced by replacing Cl- with ClO4-. It is inhibited by low concentrations of 4-acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid (SITS) and 4,4'-diisothiocyanostilbene-2.2'-disulphonic acid (DIDS), characteristic inhibitors of anion transport. Pb uptake is unaffected by varying the external concentrations of Na+, K+ and Ca2+. When Pb enters the cell, it binds mainly to haemoglobin. The ratio of bound Pb:free Pb2+ in the cytosol is estimated to be 6000:1. Pb binding to haemoglobin is unaffected by oxygenation. Binding to albumin is quantitatively similar to binding to haemoglobin. The implications of these results for the transport and binding of Pb in the blood are discussed.
This article has been cited by other articles:
![]() |
D. S. Kempe, P. A. Lang, K. Eisele, B. A. Klarl, T. Wieder, S. M. Huber, C. Duranton, and F. Lang Stimulation of erythrocyte phosphatidylserine exposure by lead ions Am J Physiol Cell Physiol, February 1, 2005; 288(2): C396 - C402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Cheong, D. Bannon, L. Olivi, Y. Kim, and J. Bressler Different Mechanisms Mediate Uptake of Lead in a Rat Astroglial Cell Line Toxicol. Sci., February 1, 2004; 77(2): 334 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Bannon, R. Abounader, P. S. J. Lees, and J. P. Bressler Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells Am J Physiol Cell Physiol, January 1, 2003; 284(1): C44 - C50. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Allain, O. Heudi, A. Cailleux, A. Le Bouil, F. Larra, M. Boisdron-Celle, and E. Gamelin Early Biotransformations of Oxaliplatin after Its Intravenous Administration to Cancer Patients Drug Metab. Dispos., November 1, 2000; 28(11): 1379 - 1384. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |